Figures & data: Genome-wide transcriptional response of MPP+-treated human neuroblastoma SH-SY5Y cells to apomorphine

725

Views

CrossRef citations to date

Altmetric

Figures & data

Table 1. Fold changes for 18 common DEGs between MPP⁺-treated SH-SY5Y cells with and without APO. DEGs of SH-SY5Y cells treated with MPP⁺ alone were obtained from the study of Choi et al. (Citation2014).

Download CSV Display Table

Table 2. Enriched GO terms in DEGs obtained from MPP⁺-treated SH-SY5Y cells with APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .01.

Download CSV Display Table

Table 3. Enriched KEGG pathways in DEGs of MPP⁺-treated SH-SY5Y cells, with and without APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .05.

Download CSV Display Table

Figure 2. DEGs in the HIF-1 signaling pathway for MPP⁺-treated SH-SY5Y cells with APO. Scale bar at the top left represents the log2 fold change.

Figure 3. P53 signaling pathway for MPP⁺-treated SH-SY5Y cells with APO. Scale bar at the top left represents the log2 fold change.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Genome-wide transcriptional response of MPP⁺-treated human neuroblastoma SH-SY5Y cells to apomorphine

Table 1. Fold changes for 18 common DEGs between MPP⁺-treated SH-SY5Y cells with and without APO. DEGs of SH-SY5Y cells treated with MPP⁺ alone were obtained from the study of Choi et al. (Citation2014).

Table 2. Enriched GO terms in DEGs obtained from MPP⁺-treated SH-SY5Y cells with APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .01.

Table 3. Enriched KEGG pathways in DEGs of MPP⁺-treated SH-SY5Y cells, with and without APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .05.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Genome-wide transcriptional response of MPP+-treated human neuroblastoma SH-SY5Y cells to apomorphine

Figures & data

Table 1. Fold changes for 18 common DEGs between MPP+-treated SH-SY5Y cells with and without APO. DEGs of SH-SY5Y cells treated with MPP+ alone were obtained from the study of Choi et al. (Citation2014).

Table 2. Enriched GO terms in DEGs obtained from MPP+-treated SH-SY5Y cells with APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .01.

Table 3. Enriched KEGG pathways in DEGs of MPP+-treated SH-SY5Y cells, with and without APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .05.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Genome-wide transcriptional response of MPP⁺-treated human neuroblastoma SH-SY5Y cells to apomorphine

Table 1. Fold changes for 18 common DEGs between MPP⁺-treated SH-SY5Y cells with and without APO. DEGs of SH-SY5Y cells treated with MPP⁺ alone were obtained from the study of Choi et al. (Citation2014).

Table 2. Enriched GO terms in DEGs obtained from MPP⁺-treated SH-SY5Y cells with APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .01.

Table 3. Enriched KEGG pathways in DEGs of MPP⁺-treated SH-SY5Y cells, with and without APO. GO terms are ranked by adjusted p-value and the cut-off for the adjusted p-value was .05.